The European Hematology Association is highly committed to organize fully compliant and independent educational and scientific meetings.
The EFPIA and MedTech compliance have recently joined forces. According to their regulations Virtual events (such as the EHA 2021 Virtual Congress) are outside their scope and therefore the congress is not submitted in the Vetting system. The European Hematology Association will still make sure they comply with the respective guidelines.
The Exhibitor or Sponsor showcasing pharmaceutical (or pharma-dependent) products is advised to consult the advice of the Codes of Practice for the Promotion of Medicines presented by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) bodies before applying. In all cases, the Exhibitor or Sponsor is responsible for ensuring that their promotion during the Congress is legally and ethically acceptable in the Netherlands (see the link to the Dutch compliance agency below). EHA is not liable in any way for sponsors not complying to legal, ethical and industry standards.
The MedTech Europe Code of Ethical Business Practice regulates all aspects of the industry’s relationship with Healthcare Professionals (HCPs) and Healthcare Organizations (HCOs), such as company-organized events, arrangements with consultants, research and financial support to medical education, amongst others.
Each company is responsible for conducting its business in full compliance with all national and international laws and regulations that pertain to its particular industry, and that prior to their application a compliance officer has approved the specific sponsorship item(s).
Dutch Code of Conduct for Pharmaceutical Advertising (CGR)
EHA2021 Virtual Congress has been approved by the CGR - the letter of confirmation can be shared upon request.
You can find the Dutch code here: https://www.cgr.nl/en-GB/Medische-congressen.